{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:12Z","timestamp":1787169852975,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"Abstract<\/jats:title>\n \n Background:<\/jats:title>\n In men under the age of 35 years, testicular cancer is the most prevalent solid tumor. Additional treatment is necessary for many people with nonseminomatus germ cell tumors (NSGCTs). Whether in conjunction with chemotherapy or as a stand-alone procedure, retroperitoneal lymph node dissection (RPLND) continues to play a critical role in the treatment of these patients. There is a lack of information in Saudi Arabian literature about the long-term oncologic outcome of NSGCT following RPLND surgery.<\/jats:p>\n <\/jats:sec>\n \n Objective:<\/jats:title>\n The study\u2019s goals were to identify clinical and pathological characteristics related with long-term survival following NSGCT for RPLND, as well as to assess the surgical and oncological results of this treatment.<\/jats:p>\n <\/jats:sec>\n \n Methodology:<\/jats:title>\n From January 2010 to April 2021, nine adults who had had orchidectomy for testicular cancer and RPLND following treatment for the evidence of persistent NSGCT disease at our hospital were included in this retrospective research. Demographic information, laboratory results, radiological findings, staging, chemotherapy and radiotherapy status, surgical procedure details, perioperative problems, morbidity, and mortality were all acquired from patients\u2019 medical records. Rates of disease return and overall survival. SPSS was utilized for the data analysis.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n During the study period, nine patients with NSGCT underwent RPLND, with a mean age of 28 years (5.4: standard deviation). The most common diseases were yolk sac and embryonal cell cancer. In addition to receiving neoadjuvant chemotherapy, all patients had a Clavien\u2013Dindo score of 2, and there was no mortality after RPLND. Overall median survival time was 26, and disease-free survival time was 21 months. Overall survival at 1 year was 86%, and at 5 years, it was 66%. The prognosis of embryonal cell cancer was more optimistic than that of a tumor of the yolk sac.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n We have shown that RPLND has an extremely low rate of morbidity and postoperative problems. In terms of oncology, it results in adequate overall and disease-free survival rates, with low morbidity and postoperative complications.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ua.ua_134_22","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:09:16Z","timestamp":1697774956000},"page":"388-392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term retroperitoneal lymph node dissection outcomes for nonseminomatous germ cell tumors with postchemotherapy retroperitoneal residual tumors, in a specialized hospital of Saudi Arabia"],"prefix":"10.4103","volume":"15","author":[{"given":"Omar","family":"Buksh","sequence":"first","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouman","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Khogeer","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Akram","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Alakra\u2019a","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Alammari","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Junaid","sequence":"additional","affiliation":[{"name":"Department of Urology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"R1-20240828","year":"2020","journal-title":"WHO"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canep.2018.08.002","article-title":"International testicular cancer incidence rates in children, adolescents and young adults","volume":"56","author":"Kusler","year":"2018","journal-title":"Cancer Epidemiology"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"772","DOI":"10.6004\/jnccn.2015.0092","article-title":"Testicular cancer, version 2 2015","volume":"13","author":"Motzer","year":"2015","journal-title":"J Natl Compr Cancer Netw"},{"key":"R4-20240828","doi-asserted-by":"crossref","DOI":"10.1007\/s11934-016-0597-z","article-title":"Robotic Primary RPLND for Stage I Testicular Cancer: A Review of Indications and Outcomes","volume":"17","author":"Chalfin","year":"2016","journal-title":"Current Urology Reports"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1756287212443170","article-title":"Retroperitoneal lymphadenectomy and resection for testicular cancer: An update on best practice","volume":"4","author":"Heidenreich","year":"2012","journal-title":"Therapeutic Advances in Urology"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1464-410X.2009.08860.x","article-title":"Surgical management of low-stage nonseminomatous germ cell testicular cancer","volume":"104","author":"Stephenson","year":"2009","journal-title":"BJU International."},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.2005.07.132","article-title":"Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome","volume":"23","author":"Stephenson","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/cncr.23233","article-title":"The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor","volume":"112","author":"Dash","year":"2008","journal-title":"Cancer"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.juro.2014.07.028","article-title":"Re: Solid Tumors after Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study","volume":"192","author":"Richie","year":"2014","journal-title":"Journal of Urology"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000020197","article-title":"RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors?","volume":"37","author":"Weissbach","year":"2000","journal-title":"European Urology"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ucl.2007.02.010","article-title":"Role of post-chemotherapy surgery in germ cell tumors","volume":"34","author":"Sim","year":"2007","journal-title":"Urol Clin North Am"},{"key":"R12-20240828","first-page":"20","article-title":"Testicular tumor at King Faisal Specialist Hospital and Research Centre - Jeddah, Kingdom of Saudi Arabia","volume":"2","author":"Nassir A","year":"2010","journal-title":"UQU Medical Journal"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0974-7796.127017","article-title":"Predictors of viable germ cell tumor in postchemotherapeutic residual retroperitoneal masses","volume":"6","author":"Al Othman","year":"2014","journal-title":"Urology Annals"},{"key":"R14-20240828","first-page":"3275","article-title":"Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture","volume":"41","author":"Einhorn","year":"1981","journal-title":"Cancer Res"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ijc.2910590108","article-title":"Testicular cancer in nine northern european countries","volume":"59","author":"Adami","year":"1994","journal-title":"International Journal of Cancer"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0022-5347(17)41361-9","article-title":"Stage I Nonseminomatous Germ Cell Testicular Tumor: Prediction of Metastatic Potential by Primary Histopathology","volume":"141","author":"Fung","year":"1989","journal-title":"Journal of Urology"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/0284186X.2021.1905176","article-title":"Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours \u2013a systematic review","volume":"60","author":"Rosenvilde","year":"2021","journal-title":"Acta Oncologica"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.athoracsur.2010.12.034","article-title":"Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum","volume":"91","author":"Kesler","year":"2011","journal-title":"The Annals of Thoracic Surgery"},{"key":"R20-20240828","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-020-02032-1","article-title":"Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature","volume":"18","author":"Ruf","year":"2020","journal-title":"World Journal of Surgical Oncology"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ua.ua_134_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:07Z","timestamp":1787166847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ua.ua_134_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ua.ua_134_22","relation":{},"ISSN":["0974-7796","0974-7834"],"issn-type":[{"value":"0974-7796","type":"print"},{"value":"0974-7834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2022-10-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}